ROS, stress-activated kinases and stress signaling in cancer

EMBO Reports

Volumn 3, Issue 5, 2002, Pages 420-425

  Benhar, Moran ^a   Engelberg, David ^a   Levitzki, Alexander ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; CISPLATIN; CYCLIN D1; CYTOTOXIC AGENT; DNA; DOXORUBICIN; EPIDERMAL GROWTH FACTOR; ETOPOSIDE; GLUTATHIONE TRANSFERASE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN C JUN; PROTEIN P53; PROTEIN TYROSINE KINASE; PROTEIN V FOS; RAS PROTEIN; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; THIOREDOXIN; TRANSCRIPTION FACTOR; TRASTUZUMAB;

ADVANCED CANCER; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CANCER STAGING; CARCINOGENESIS; CELL DEATH; CELL SPECIFICITY; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOSKELETON; DNA DAMAGE; DOWN REGULATION; EARLY CANCER; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ENZYMOLOGY; METABOLISM; NEOPLASM; OXIDATIVE STRESS;

ANIMAL; APOPTOSIS; HUMAN; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASMS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; ANIMALS; HUMANS;

EID: 0035984912     PISSN: 1469221X     EISSN: None     Source Type: Journal    
DOI: 10.1093/embo-reports/kvf094     Document Type: Review

References (58)

1. Role of redox potential and reactive oxygen species in stress signaling
2. Epidermal growth factor (EGF)-induced generation of hydrogen peroxide Role in EGF receptor-mediated tyrosine phosphorylation
3. 2 production requires the activation of phosphatidylinositol 3-kinase
4. Oncogenic transformation by ras and fos is mediated by c-Jun N-terminal phosphorylation
5. Enhanced ROS production in oncogenically transformed cells potentiates c-jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stress
6. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells
7. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
8. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation
9. Mitochondrial redox signaling during apoptosis
10. Oncogenic transformation potentiates apoptosis, S-phase arrest and stress-kinase activation by etoposide
11. 2-terminal kinase-2-deficient mice
12. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. Duration of JNK activation may determine cell death and proliferation
13. Down-regulation of the c-Jun N-terminal kinase (JNK) phosphatase M3/6 and activation of JNK by hydrogen peroxide and pyrrolidine dithiocarbamate
14. Multiple mitogen-activated protein kinase signaling pathways connect the cot oncoprotein to the c-jun promoter and to cellular transformation
15. Signal transduction by the JNK group of MAP kinases
16. Cellular thiols and reactive oxygen species in drug-induced apoptosis
17. Proliferation, cell cycle and apoptosis in cancer
18. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines
19. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts
20. Reactive oxygen intermediates as mediators of programmed cell death in plants and animals
21. The contribution of endogenous sources of DNA damage to the multiple mutations in cancer
22. Redox regulation of cellular signalling
23. Induction of apoptosis by cancer chemotherapy
24. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation
25. Mitogen-activated protein kinase phosphatase-1 (MKP-1) expression is induced by low oxygen conditions found in solid tumor microenvironments. A candidate MKP for the inactivation of hypoxia-inducible kinase/c-Jun N-terminal protein kinase activity
26. pp60(v-src) induction of cyclin D1 requires collaborative interactions between the extracellular signal-regulated kinase, p38, and jun kinase pathways. A role for cAMP response element-binding protein and activating factor-2 in pp60(v-src) signaling in breast cancer cells
27. Signal transduction through MAP kinase cascades
28. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin
29. Apoptosis in cancer
30. Mitogen-activated protein kinase phosphatase 1 is overexpressed in prostate cancers and is inversely related to apoptosis
31. Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin
32. Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2
33. Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases
34. 1 phase of the cell cycle
35. Trastuzumab and chemotherapeutics: Drug interactions and synergies
36. A model for p53-induced apoptosis
37. c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells
38. 2 by catalase inhibits the proliferation of HER-2/Neu-transformed rat-1 fibroblasts through the induction of a stress response
39. Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer
40. The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation
41. Activation of the JNK pathway is essential for transformation by the Met oncogene
42. 1 phase cell cycle machinery
43. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1
44. A role for the p38 mitogen-activated protein kinase pathway in the transcriptional activation of p53 on genotoxic stress by chemotherapeutic agents
45. Importance of glutathione and associated enzymes in drug response
46. 2-terminal kinase and subsequent CPP32/Yama during topoisomerase inhibitor β-lapachone-induced apoptosis through an oxidation-dependent pathway
47. Cell transformation by the superoxide-generating oxidase Mox1
48. Production of large amounts of hydrogen peroxide by human tumor cells
49. Downstream of Crk adaptor signaling pathway: Activation of Jun kinase by v-Crk through the guanine nucleotide exchange protein C3G
50. Kit signaling through PI 3-kinase and Src kinase pathways: An essential role for Rac1 and JNK activation in mast cell proliferation
51. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis
52. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
53. Enhancement of chemosensitivity by tyrphostin AG825 in high-p185(neu) expressing non-small cell lung cancer cells
54. 2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells
55. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17
56. Regulation of Myc-dependent apoptosis by p53, c-Jun N-terminal kinases/stress-activated protein kinases, and Mdm-2
57. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model